Novimmune Competitors and Similar CompaniesClear all

Novimmune's competitors and similar companies include Valneva and Alembic Pharmaceuticals.
Novimmune
Novimmune
Novimmune is a company that focuses on its bispecific technology to build a pipeline of multispecific antibodies under the brand Light Chain Bioscience.
Valneva
Valneva
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.
Alembic Pharmaceuticals
Alembic Pharmaceuticals
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
Founding Date
Founding Date
1998
Founding Date
2013
Founding Date
2010
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Plan-les-Ouates, CH HQ
Locations
Saint-Herblain, FR HQ
Wien, AT
Kirkland, CA
Lyon, FR
Solna, SE
Fleet, GB
Livingston, GB
see more
Locations
Vadodara, IN HQ
Baska, IN
Mumbai, IN
Namthang, IN
Vadodara, IN
Vadodara, IN
Employees
Employees
80
Employees
713
Employees
14,858

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€157.9m (FY, 2025)
Revenue (est.)
₹73.4b (FY, 2026)
Cost of goods
Cost of goods
N/A
Cost of goods
€8.2m (FY, 2025)
Cost of goods
₹19.8b (FY, 2026)
Gross profit
Gross profit
N/A
Gross profit
€177.7m (FY, 2025)
Gross profit
₹54.1b (FY, 2026)
Net income
Net income
N/A
Net income
(€115.2m) (FY, 2025)
Net income
₹6.7b (FY, 2026)

Funding

Total funding raised
Total funding raised
$ 239.1m
Total funding raised
$ 51.7m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Valneva
HQ
Saint-Herblain, FR
Employees
713

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.

View company
Alembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858

Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates

View company